Evidence map›Paper›PMID 41053842›Full record

ArticleGenome biology2025

Silent mutations in coding regions of Hepatitis C virus affect patterns of HCV RNA structures and attenuate viral replication and pathogenesis.

Roba Dabour, Shaked Bergman, Zohar Zafrir, Ateret Davidovitch, Michal Werbner, Meital Gal-Tanamy, Tamir Tuller

Abstract read
In one paragraph

Article in Genome biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Roba Dabour *Molecular Virology Laboratory, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Shaked Bergman *Department of Biomedical Engineering, Tel-Aviv University, Tel Aviv, Israel.
Zohar ZafrirDepartment of Biomedical Engineering, Tel-Aviv University, Tel Aviv, Israel.
Ateret DavidovitchMolecular Virology Laboratory, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Michal WerbnerMolecular Virology Laboratory, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Meital Gal-TanamyMolecular Virology Laboratory, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. Meital.Tanamy@biu.ac.il.
Tamir TullerDepartment of Biomedical Engineering, Tel-Aviv University, Tel Aviv, Israel. tamirtul@tauex.tau.ac.il.

Funding

The Edmond J. Safra Center for Bioinformatics at Tel Aviv University. NONthe Israel Science Foundation 3380/24
6 · The paper itself

Abstract

backgroundVaccines based on live attenuated viruses are the most effective strategy for controlling infections, since they elicit long-lasting natural and effective immune response, but entail challenges for safety and virulence. Hepatitis C Virus (HCV) causes liver diseases and liver cancer, with millions infected each year and hundreds of thousands of annual fatalities; but no vaccine is currently available for the virus. Here, we present a novel computational approach for the accurate prediction of virus attenuation.

resultsWe rationally design viral variants by inserting a large number of synonymous mutations in the NS5A/B coding region to disrupt the viral RNA's secondary structure and regulatory sequences important for the viral life cycle. By measuring RNA levels and virus spread in an HCV infection model, we show that some variants have lower viral fitness relative to the wild-type virus, with gradient of attenuation in concordance with the prediction model. Deep sequencing of replicating viruses demonstrates relative genomic stability of the attenuated variant. Differential expression analysis and evaluation of cancer-related phenotypes reveal that some variants have a lower pathogenic influence on the host cells, compared to the wildtype virus.

conclusionsThese rationally designed variants reveal novel information on key functional elements in HCV RNA important for virus fitness, that may be further considered as a promising direction for a viable HCV vaccine. Importantly, the computational approach described here is based on the most fundamental viral regulatory motifs and therefore may be applied for almost all viruses as a new strategy for vaccine development.

Indexed as

HepacivirusMutationOpen Reading FramesRNA, ViralVirus ReplicationHepatitis CHumansNucleic Acid ConformationRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsNS-5 protein, hepatitis C virusRNA-Dependent RNA PolymeraseRNA, ViralViral Nonstructural ProteinsComputational biology and bioinformaticsHepatitis C virusMRNA secondary structureSynonymous mutationsVaccines

Identifiers

PMID41053842
PMCPMC12498475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.